There is an unnamed epidemic slowly traveling through the middle of the U.S. This epidemic goes by many names, but our venture fund refers to it as “early exit disease.” This disease spreads when founders realize sub-$20 million exits. Many of these exits could have grown much larger. Instead, early exits have been quietly devastating the Midwest region’s startup… Read More